J. B. Chemicals & Pharmaceuticals Overview

  • Year Founded
  • 1976

Year Founded

  • Status
  • Public

  • Employees
  • 7,386

Employees

  • Stock Symbol
  • 506943

Stock Symbol

  • Investments
  • 10

  • Share Price
  • $23.27
  • (As of Thursday Closing)

J. B. Chemicals & Pharmaceuticals General Information

Description

J.B. Chemicals & Pharmaceuticals Ltd is an India-based pharmaceutical company. It manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (APIs). The company's products include various pharmaceutical dosage forms like tablets, injectable, creams, ointments, lozenges, herbal liquids, and capsules. It also offers services including optimization of formulations, scale-up services, stability testing, regulatory support, packaging design, and commercial production. The group derives revenue from the manufacturing and marketing of a diverse range of pharmaceutical products. The company sells its products in India and also exports them to other international countries.

Contact Information

Formerly Known As
J. B. Mody Chemicals & Pharmaceuticals
Ownership Status
Publicly Held
Financing Status
Private Equity-Backed
Corporate Office
  • Cnergy IT Park, Unit A2, 3th floor & Unit A, 8th floor
  • Appa Saheb Marathe Marg, Prabhadevi
  • Mumbai, Maharashtra 400025
  • India
+91 022
Primary Industry
Pharmaceuticals
Stock Exchange
BOM
Vertical(s)
Corporate Office
  • Cnergy IT Park, Unit A2, 3th floor & Unit A, 8th floor
  • Appa Saheb Marathe Marg, Prabhadevi
  • Mumbai, Maharashtra 400025
  • India
+91 022

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

J. B. Chemicals & Pharmaceuticals Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$23.27 $22.34 $16.52 - $24.17 $3.61B 155M 5.3K $0.46

J. B. Chemicals & Pharmaceuticals Financials Summary

In Thousands,
USD
TTM 30-Jun-2024 FY 2024 31-Mar-2024 FY 2023 31-Mar-2023 FY 2022 31-Mar-2022
EV 3,266,633 3,070,134 1,875,429 1,509,510
Revenue 427,895 416,457 388,118 325,368
EBITDA 117,636 112,224 87,488 78,204
Net Income 70,654 66,754 51,039 51,721
Total Assets 478,949 432,866 343,856
Total Debt 0 45,286 69,725 7,195
Public Fundamental Data provided by Morningstar, Inc. disclaimer

J. B. Chemicals & Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore J. B. Chemicals & Pharmaceuticals‘s full profile, request access.

Request a free trial

J. B. Chemicals & Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
J.B. Chemicals & Pharmaceuticals Ltd is an India-based pharmaceutical company. It manufactures and markets pharmaceutica
Pharmaceuticals
Mumbai, India
7,386 As of 2024

Mumbai, India
 

Bangalore, India
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

J. B. Chemicals & Pharmaceuticals Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Indoco Remedies Corporation Mumbai, India
Bal Pharma Corporation Bangalore, India
Emcure Pharmaceuticals Formerly PE-Backed Pune, India
You’re viewing 3 of 3 competitors. Get the full list »

J. B. Chemicals & Pharmaceuticals Patents

J. B. Chemicals & Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2782734-A1 Nicotine containing formulation Active 16-Sep-2010
EP-2496083-A1 Nicotine containing formulation Inactive 16-Sep-2010
CA-2782734-C Nicotine containing formulation Active 16-Sep-2010
AU-2010360967-A1 Nicotine containing formulation Active 16-Sep-2010
AU-2010360967-B2 Nicotine containing formulation Active 16-Sep-2010 A61K31/465
To view J. B. Chemicals & Pharmaceuticals’s complete patent history, request access »

J. B. Chemicals & Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

J. B. Chemicals & Pharmaceuticals Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore J. B. Chemicals & Pharmaceuticals‘s full profile, request access.

Request a free trial

J. B. Chemicals & Pharmaceuticals Investments & Acquisitions (10)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Novartis (Eyecare Portfolio in India) 12-Dec-2023 Buildings and Property
Glenmark Pharmaceuticals (Razel) 22-Dec-2022 Pharmaceuticals
Dr. Reddy's Laboratories (Four Paediatric Brands) 30-Jun-2022 Buildings and Property
Biotech Laboratories 01-Jun-2022 Distributors (Healthcare)
Novartis (Azmarda) 01-Apr-2022 Buyout/LBO Buildings and Property
You’re viewing 5 of 10 investments and acquisitions. Get the full list »

J. B. Chemicals & Pharmaceuticals Subsidiaries (1)

Company Name Industry Location Founded
Biotech Laboratories Distributors (Healthcare) Midrand, South Africa
To view J. B. Chemicals & Pharmaceuticals’s complete subsidiaries history, request access »

J. B. Chemicals & Pharmaceuticals ESG

Risk Overview

Risk Rating

Updated March, 31, 2023

27.15 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 16,009

Rank

Percentile

Pharmaceuticals

Industry

of 909

Rank

Percentile

Pharmaceuticals

Subindustry

of 446

Rank

Percentile

To view J. B. Chemicals & Pharmaceuticals’s complete esg history, request access »

J. B. Chemicals & Pharmaceuticals Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
HBS Pharma SEZ 08-Oct-2007 Completed
  • 2 buyers
To view J. B. Chemicals & Pharmaceuticals’s complete exits history, request access »

J. B. Chemicals & Pharmaceuticals FAQs

  • When was J. B. Chemicals & Pharmaceuticals founded?

    J. B. Chemicals & Pharmaceuticals was founded in 1976.

  • Where is J. B. Chemicals & Pharmaceuticals headquartered?

    J. B. Chemicals & Pharmaceuticals is headquartered in Mumbai, India.

  • What is the size of J. B. Chemicals & Pharmaceuticals?

    J. B. Chemicals & Pharmaceuticals has 7,386 total employees.

  • What industry is J. B. Chemicals & Pharmaceuticals in?

    J. B. Chemicals & Pharmaceuticals’s primary industry is Pharmaceuticals.

  • Is J. B. Chemicals & Pharmaceuticals a private or public company?

    J. B. Chemicals & Pharmaceuticals is a Public company.

  • What is J. B. Chemicals & Pharmaceuticals’s stock symbol?

    The ticker symbol for J. B. Chemicals & Pharmaceuticals is 506943.

  • What is the current stock price of J. B. Chemicals & Pharmaceuticals?

    As of 31-Oct-2024 the stock price of J. B. Chemicals & Pharmaceuticals is $23.27.

  • What is the current market cap of J. B. Chemicals & Pharmaceuticals?

    The current market capitalization of J. B. Chemicals & Pharmaceuticals is $3.61B.

  • What is J. B. Chemicals & Pharmaceuticals’s current revenue?

    The trailing twelve month revenue for J. B. Chemicals & Pharmaceuticals is $428M.

  • Who are J. B. Chemicals & Pharmaceuticals’s competitors?

    Indoco Remedies, Bal Pharma, and Emcure Pharmaceuticals are competitors of J. B. Chemicals & Pharmaceuticals.

  • What is J. B. Chemicals & Pharmaceuticals’s annual earnings per share (EPS)?

    J. B. Chemicals & Pharmaceuticals’s EPS for 12 months was $0.46.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »